12.3 Genome Mapping, Characterizing & Sequencing (Biotechnology)

12.3 Genome Mapping, Characterizing & Sequencing (Biotechnology)

Quick Answer: Genome mapping locates genes on chromosomes using genetic (recombination-based, cM) and physical (base-pair-based, kb/Mb) maps. Sanger sequencing terminates growing DNA chains with dideoxynucleotides; next-generation sequencing (NGS) parallelizes this to billions of short reads. PCR amplifies specific DNA regions exponentially with a thermostable polymerase. Restriction enzymes cut DNA at palindromic sites to enable cloning, RFLP analysis, and recombinant DNA technology.

Genetic vs Physical Maps

A genetic (linkage) map orders markers by recombination frequency. One centiMorgan (cM) equals a 1% chance of recombination between two loci per meiosis; roughly, 1 cM ≈ 1 Mb in humans, though this varies with recombination hotspots. Genetic maps are built from family studies and crosses.

A physical map measures actual base-pair distances. The highest-resolution physical map is the complete nucleotide sequence itself. Intermediate physical maps include cytogenetic maps (banding patterns on stained chromosomes), STS maps (sequence-tagged sites), and contig maps (overlapping cloned fragments). Bridging genetic and physical maps is essential: a disease locus identified by linkage (genetic) must be pinpointed in base pairs (physical) to identify the responsible gene.

DNA Sequencing

Sanger sequencing (Frederick Sanger, 1977) is the chain-termination method. A single-stranded template is primed and extended by DNA polymerase in the presence of normal dNTPs plus a small amount of dideoxynucleotides (ddNTPs), which lack the 3'-OH needed for the next phosphodiester bond. Incorporation of a ddNTP halts the chain. Historically run in four lanes (one per ddNTP) with radioactive or fluorescent labels, modern capillary electrophoresis reads ~800–1000 bp per reaction and was the workhorse of the Human Genome Project's finishing phase.

Next-generation sequencing (NGS) eschews single reactions for massively parallel sequencing of millions to billions of clusters. Illumina's sequencing-by-synthesis uses reversible terminators and fluorescent imaging; other platforms (Ion Torrent, Oxford Nanopore, PacBio) measure pH changes or ionic current as DNA passes through a pore. NGS yields massive throughput (a single run can produce >1 Tb of data) but shorter reads (50–300 bp for Illumina), which are assembled computationally against a reference. Long-read technologies (Nanopore, PacBio) produce reads of 10–100 kb, resolving repetitive regions short-read assemblers struggle with.

Polymerase Chain Reaction (PCR)

PCR (Mullis, 1983) amplifies a defined DNA region exponentially (2ⁿ copies after n cycles). Each cycle has three temperature steps:

1. Denaturation (~95°C): separate the double helix into single strands.
2. Annealing (~50–65°C): primers bind flanking the target.
3. Extension (~72°C): Taq polymerase (from Thermus aquaticus) synthesizes the complementary strand from dNTPs.

A typical run does 25–40 cycles, producing up to a billion copies from a single template. RT-PCR uses reverse transcriptase to first convert RNA to cDNA; qPCR (real-time PCR) quantifies amplicon accumulation with fluorescent dyes or probes, the basis of clinical viral load tests.

Restriction Enzymes and Recombinant DNA

Restriction endonucleases recognize palindromic sequences (reads same 5'→3' on both strands) and cleave there. EcoRI cuts G↓AATTC, leaving 5' overhangs ("sticky ends"); HaeIII cuts GG↓CC, leaving blunt ends. Sticky ends pair with complementary sticky ends on a vector, sealed by DNA ligase.

A typical cloning workflow: cut insert and plasmid vector with the same enzyme, ligate, transform into E. coli, select on antibiotic medium (the plasmid carries a resistance gene), and screen colonies. Gel electrophoresis separates DNA fragments by size (smaller migrate faster through agarose); RFLP analysis compares fragment patterns to detect mutations at restriction sites. These tools underpin recombinant protein production (e.g., recombinant insulin), transgenic organisms, gene therapy, CRISPR-Cas9 genome editing, and molecular diagnostics including PCR-based pathogen detection.

Genome Characterizing and Applications

Beyond raw sequence, characterizing a genome means annotating genes, regulatory elements, repeats, and variation. Bioinformatics pipelines align reads to a reference, call variants (SNPs, indels, structural variants), and predict gene function by homology. Comparative genomics aligns related genomes to find conserved (likely functional) regions, while GWAS correlates variants with phenotypes such as disease risk. CRISPR-Cas9 uses a guide RNA to direct the Cas9 nuclease to a complementary genomic sequence, producing targeted double-strand breaks exploited for gene knockout, knock-in, or base editing; this is the modern extension of the recombinant-DNA toolkit and a frequent PA-CAT-relevant application of biotechnology.

Why This Matters for the PA-CAT

The PA-CAT Bulletin of Information (rev. 20240815) groups Biotechnology within General Biology. Expect questions that (a) distinguish genetic from physical maps and their units (cM vs kb), (b) identify the chain-terminating agent in Sanger sequencing (ddNTPs), (c) describe PCR steps and the role of Taq polymerase's thermostability, and (d) recognize restriction enzyme behavior (palindromic recognition, sticky vs blunt ends). Understanding how these tools combine—PCR to amplify, restriction enzymes to cut, vectors to clone, sequencing to read—is the integrative level the exam probes.